TRYPTASE LEVELS AS AN INDICATOR OF MAST-CELL ACTIVATION IN SYSTEMIC-ANAPHYLAXIS AND MASTOCYTOSIS
TRYPTASE LEVELS AS AN INDICATOR OF MAST-CELL ACTIVATION IN SYSTEMIC-ANAPHYLAXIS AND MASTOCYTOSIS
复制标题
DOI:
10.1056/nejm198706253162603
复制
发表时间:
1987-06-25
影响因子:
158.5
通讯作者:
SULLIVAN, T
中科院分区:
文献类型:
--
作者:
SCHWARTZ, LB;METCALFE, DD;SULLIVAN, T
Better methods are needed to assess mast-cell activation in vivo and to distinguish the activation of mast cells from that of basophils. Tryptase, a neutral protease selectively concentrated in the secretory granules of human mast cells (but not basophils), is released by mast cells together with histamine and serves as a marker of mast-cell activation. In 17 patients with systemic mastocytosis, concentrations of tryptase in plasma were linearly related to those of histamine (P < 0.01). Eleven of the 17 patients had tryptase levels of 4 to 88 ng per milliter, indicating ongoing mast-cell activation. In each of six patients who experienced corresponding anaphylactic reactions after penicillin, aspirin, or melon ingestion, a wasp sting, exercise, or antilymphocyte globulin injection, tryptase levels in serum ranged from 9 to 75 ng per milliliter, indicating mast-cell activation during each of these events. In contrast, serum tryptase levels were less than 5 ng per milliliter in all patients presenting with myocardial disease (n = 8, 6 with hypotension) or sepsis (n = 6, 3 with hypotension) and in the controls (n = 20). One patient had a myocardial infarction after anaphylaxis in response to a wasp sting and an elevated tryptase level of 25 ng per milliliter. Thus, the plasma or serum tryptase level is a diagnostic correlate of mast-cell-related events.